Status:
UNKNOWN
Melatonin and Salt on Blood Vessel Function
Lead Sponsor:
University of Delaware
Conditions:
Cardiovascular Risk Factor
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Increased dietary sodium causes increases in oxidative stress and damages blood vessels. Americans eat more than the recommended amount of sodium. Melatonin is a powerful endogenous antioxidant that h...
Detailed Description
Americans consume on average double the recommended amount of sodium established by organizations such as the American Heart Association and the Dietary Guidelines for Americans. Excess dietary sodium...
Eligibility Criteria
Inclusion
- healthy
- normal blood pressure
Exclusion
- hypertension
- heart disease
- diabetes
- kidney disease
- renal impairment
- cancer
- obese (BMI ≥30)
- sleep disorder
- use of tobacco products
- pregnant or breastfeeding
- take any medications for the above conditions
- endurance trained athletes
- night shift worker
- melatonin or antioxidant consumption for the previous 3 months
- use of selective serotonin reuptake inhibitors
Key Trial Info
Start Date :
March 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04325191
Start Date
March 12 2020
End Date
September 30 2022
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Delaware
Newark, Delaware, United States, 19711